Ellis Wilson, Jr., M.S., E.M.B.A.
Vice President, Global Clinical Operations
Ellis Wilson, Jr., M.S., E.M.B.A. brings over 25 years of experience planning, executing and delivering drug development programs across multiple therapeutic areas and all phases of development. Prior to joining Vistagen, he served as Vice President, Clinical Development at NRX Pharma (Nasdaq: NRXP) where he was responsible for late-stage clinical programs. Mr. Wilson has also served as Executive Director, Commercial Strategy Lead for Neuroscience at PPD and Vice President, Product Development at WavoDyne Therapeutics. He worked nearly 15 years at AstraZeneca, where he was integrally involved in many key development programs. Roles at Merck and NovoNordisk round out his clinical development experience. Mr. Wilson earned his Executive M.B.A. in Pharmaceutical Marketing from Saint Joseph’s University Haub School of Business; his M.S. in Quality Assurance & Regulatory Affairs from Temple University School of Pharmacy; his M.S. in Health Services Administration from West Chester University; and his B.S. in Pharmacy from Philadelphia College of Pharmacy and Science.